 0 Table of Contents |
  1 Home |
  2 Changes |
  3 Copyrights |
  4 Data Types Defined in This Guide |
  5 Design Conventions |
  6 Downloads |
  7 Empty Sections and Missing Data |
  8 Examples |
  9 General Principles |
  10 Generation and Data Inclusion |
  11 Known Issues and Future Development |
  12 Must Support and Obligations |
  13 Privacy and Security Considerations |
  14 Profiles |
  15 Structure of the International Patient Summary |
  16 Terminology |
  17 Artifacts Summary |
   17.1 Consumer (IPS) |
   17.2 Producer (IPS) |
   17.3 IPS Server Capability Statement |
   17.4 IPS Summary |
   17.5 AllergyIntolerance (IPS) |
   17.6 Bundle (IPS) |
   17.7 Composition (IPS) |
   17.8 Condition (IPS) |
   17.9 Device (IPS) |
   17.10 Device - Performer or Observer (IPS) |
   17.11 DeviceUseStatement (IPS) |
   17.12 DiagnosticReport (IPS) |
   17.13 Flag - Alert (IPS) |
   17.14 ImagingStudy (IPS) |
   17.15 Immunization (IPS) |
   17.16 Medication (IPS) |
   17.17 MedicationRequest (IPS) |
   17.18 MedicationStatement (IPS) |
   17.19 Observation Pregnancy - Expected Delivery Date (IPS) |
   17.20 Observation Pregnancy - Outcome (IPS) |
   17.21 Observation Pregnancy - Status (IPS) |
   17.22 Observation Results - Laboratory/Pathology (IPS) |
   17.23 Observation Results - Radiology (IPS) |
   17.24 Observation Social History - Alcohol Use (IPS) |
   17.25 Observation Social History - Tobacco Use (IPS) |
   17.26 Organization (IPS) |
   17.27 Patient (IPS) |
   17.28 Practitioner (IPS) |
   17.29 PractitionerRole (IPS) |
   17.30 Procedure (IPS) |
   17.31 Specimen (IPS) |
   17.32 Codeable Concept (IPS) |
   17.33 Coding with translations |
   17.34 Quantity (IPS) |
   17.35 Range (IPS) |
   17.36 Ratio (IPS) |
   17.37 SimpleQuantity (IPS) |
   17.38 Allergies & Intolerances - IPS |
   17.39 Allergy Reaction - IPS |
   17.40 Body Site - IPS |
   17.41 Current Smoking Status - IPS |
   17.42 Diagnostics Report Status Codes - IPS |
   17.43 Healthcare Professional Roles - IPS |
   17.44 Imaging Study Status Codes - IPS |
   17.45 Medical Devices - IPS |
   17.46 Medications - example (IPS) |
   17.47 Medications - IPS |
   17.48 Medicine Active Substances - IPS |
   17.49 Medicine Doseform - IPS |
   17.50 Medicine Route of Administration - IPS |
   17.51 Personal Relationship - IPS [Deprecated] |
   17.52 Pregnancy Expected Delivery Date Method - IPS |
   17.53 Pregnancy Outcome - IPS |
   17.54 Pregnancy Status - IPS |
   17.55 Problem Type (LOINC) |
   17.56 Problem Type - IPS |
   17.57 Problems - IPS |
   17.58 Procedures - IPS |
   17.59 Results Coded Values Laboratory/Pathology - IPS |
   17.60 Results Laboratory/Pathology Observation - IPS |
   17.61 Results Radiology Measurement Observation - IPS |
   17.62 Results Radiology Observation - IPS |
   17.63 Results Radiology Textual Observation - IPS |
   17.64 Results Specimen Collection Method - IPS |
   17.65 Results Specimen Type - IPS |
   17.66 Results Status Codes - IPS |
   17.67 Vaccine Target Diseases - IPS |
   17.68 Vaccines - IPS |
   17.69 Vaccines WHO ATC - IPS |
   17.70 WHO ATC - IPS |
   17.71 AllergyIntolerance - Multiple Codings |
   17.72 AllergyIntolerance - No Known Allergies |
   17.73 AllergyIntolerance - Resolved Allergy |
   17.74 Bundle - IPS with Data |
   17.75 Bundle - IPS with Required Sections and Immunization |
   17.76 Bundle - Minimal Complete IPS |
   17.77 Bundle - No Information in Required Sections |
   17.78 Composition - Minimal Sections |
   17.79 Condition - Acute Myeloid Leukemia |
   17.80 Device - Device Observer |
   17.81 Device - No Known Devices in Use |
   17.82 DeviceUseStatement - No Known Devices in Use |
   17.83 DiagnosticReport - Hemoglobin |
   17.84 Flag - Alert of Patient Immunocompromised |
   17.85 ImagingStudy - Referred DICOM Study |
   17.86 Immunization - Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg) |
   17.87 Medication - Simvastatin 40 MG Disintegrating Oral Tablet |
   17.88 MedicationRequest - Simvastatin Request |
   17.89 MedicationStatement - Ongoing Simvastatin Treatment |
   17.90 Observation - Social History Alcohol Use |
   17.91 Observation: estrogen receptor in tissue example |
   17.92 Observation: hemoglobin example |
   17.93 Observation: imaging Chest X-ray - PA and lateral, with additional sub-observation including numeric range |
   17.94 Observation: imaging CT Abdomen W contrast IV |
   17.95 Observation: imaging CT Abdomen W contrast IV, sub-observations |
   17.96 Observation: pregnancy edd example |
   17.97 Observation: pregnancy outcome example |
   17.98 Observation: pregnancy status example |
   17.99 Observation: serum creatinine example |
   17.100 Observation: SH tobacco use example |
   17.101 Observation: urine wbc range example |
   17.102 Organization - Minimal Name Only |
   17.103 Organization: example |
   17.104 Organization: lab example |
   17.105 Patient: female patient |
   17.106 Patient: male patient |
   17.107 Patient: minimal example |
   17.108 Practitioner example |
   17.109 PractitionerRole - Minimal |
   17.110 Procedure: Surgical procedure |
   17.111 Specimen: example |